Eligible Clinician eCQMs

eCQM Resources
EC eCQMs
About

2024 Performance Period Eligible Clinician Resources

eCQM Resources	Short Description	Published
Implementation Checklist eCQM Annual Update	Implementation checklist	May 2023
Telehealth Guidance for eCQMs for Eligible Clinician 2024 Quality Reporting	List of telehealth eligibility of eligible clinician eCQMs	May 2023
Guide for Reading eCQMs v9.0	Assists implementers and measured entities with information on how to read eCQM specifications	May 2023
Eligible Clinicians Table of eCQMs	List of eCQMs available for use	May 2023
eCQM Specifications for Eligible Clinicians	eCQM technical specifications	May 2023
Measure Authoring Tool (MAT) Global Common Library (GCL) Technical Specifications	MAT-CGL specifications	May 2023
eCQM and Hybrid Measure Value Sets	Value sets used with eCQMs and Hybrid Measures	May 2023
eCQM Direct Reference Codes List	eCQM Direct Reference Codes used in eCQMs	May 2023
Binding Parameter Specification (BPS)	Value set metadata	May 2023
eCQM Logic and Implementation Guidance v7.0	Assists implementers and measured entities with how to use eCQMs and report issues	May 2023
Standards and tool versions used for reporting/performance period	Tools and standards versions measure developers used to create eCQMs and versions of standards and tools used for their reporting	Mar 2023
Technical Release Notes	Year over year changes to eCQMs, including logic and terminology	May 2023
Technical Release Notes	Year over year changes to eCQMs, including logic and terminology	May 2023
eCQM Annual Update Pre-Publication Document	Standards and code system versions for the eCQM Annual Update	Feb 2023

2024 Performance Period Eligible Clinician eCQMs
Total number of EC eCQMs: 50

Title	CMS eCQM ID	NQF Number	MIPS Quality ID	Telehealth Eligible*	Notes
Adult Major Depressive Disorder (MDD): Suicide Risk Assessment	CMS161v12	Not Applicable	107	Yes
Anti-depressant Medication Management	CMS128v12	Not Applicable	009	Yes
Appropriate Testing for Pharyngitis	CMS146v12	Not Applicable	066	Yes
Appropriate Treatment for Upper Respiratory Infection (URI)	CMS154v12	Not Applicable	065	Yes
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture	CMS249v6	3475e	472	Yes
Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy	CMS645v7	Not Applicable	462	Yes
Breast Cancer Screening	CMS125v12	Not Applicable	112	Yes
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery	CMS133v12	0565e	191	No
Cervical Cancer Screening	CMS124v12	Not Applicable	309	Yes
Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment	CMS177v12	Not Applicable	382	Yes
Childhood Immunization Status	CMS117v12	Not Applicable	240	Yes
Children Who Have Dental Decay or Cavities	CMS75v12	Not Applicable	378	No
Chlamydia Screening in Women	CMS153v12	Not Applicable	310	Yes
Closing the Referral Loop: Receipt of Specialist Report	CMS50v12	Not Applicable	374	Yes
Colorectal Cancer Screening	CMS130v12	Not Applicable	113	Yes
Controlling High Blood Pressure	CMS165v12	Not Applicable	236	Yes
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF)	CMS145v12	0070e	007	Yes
Dementia: Cognitive Assessment	CMS149v12	2872e	281	Yes
Depression Remission at Twelve Months	CMS159v12	0710e	370	Yes
Diabetes: Eye Exam	CMS131v12	Not Applicable	117	Yes
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)	CMS122v12	Not Applicable	001	Yes
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care	CMS142v12	Not Applicable	019	No
Documentation of Current Medications in the Medical Record	CMS68v13	Not Applicable	130	Yes
Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level)	CMS1056v1	3633e, 3662e	TBD	No	This pre-rulemaking measure is under consideration for inclusion in the 2024 performance period.
Falls: Screening for Future Fall Risk	CMS139v12	Not Applicable	318	Yes
Follow-Up Care for Children Prescribed ADHD Medication (ADD)	CMS136v13	Not Applicable	366	Yes
Functional Status Assessment for Total Hip Replacement	CMS56v12	Not Applicable	376	Yes
Functional Status Assessments for Heart Failure	CMS90v13	Not Applicable	377	Yes
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)	CMS135v12	0081e	005	Yes
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)	CMS144v12	0083e	008	Yes
HIV Screening	CMS349v6	Not Applicable	475	Yes
HIV Viral Suppression	CMS314v1	Not Applicable	338	Yes	This pre-rulemaking measure is under consideration for inclusion in the 2024 performance period.
Initiation and Engagement of Substance Use Disorder Treatment	CMS137v12	Not Applicable	305	Yes
Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer	CMS646v4	Not Applicable	481	No
Kidney Health Evaluation	CMS951v2	Not Applicable	488	Yes
Oncology: Medical and Radiation - Pain Intensity Quantified	CMS157v12	0384e	143	Yes
Pneumococcal Vaccination Status for Older Adults	CMS127v12	Not Applicable	111	Yes
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan	CMS69v12	Not Applicable	128	No
Preventive Care and Screening: Influenza Immunization	CMS147v13	Not Applicable	110	Yes
Preventive Care and Screening: Screening for Depression and Follow-Up Plan	CMS2v13	Not Applicable	134	Yes
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented	CMS22v12	Not Applicable	317	No
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	CMS138v12	Not Applicable	226	Yes
Primary Caries Prevention Intervention as Offered by Dentists	CMS74v13	Not Applicable	379	No
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation	CMS143v12	0086e	012	No
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients	CMS129v13	Not Applicable	102	No
Sexually Transmitted Infection (STI) Testing for People with HIV	CMS1188v1	Not Applicable	205	Yes	This pre-rulemaking measure is under consideration for inclusion in the 2024 performance period.
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	CMS347v7	Not Applicable	438	Yes
Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia	CMS771v5	Not Applicable	476	No
Use of High-Risk Medications in Older Adults	CMS156v12	Not Applicable	238	Yes
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents	CMS155v12	Not Applicable	239	Yes

Each year, CMS updates the electronic clinical quality measures (eCQMs) for potential use in CMS quality reporting programs and publishes them on the eCQI Resource Center. CMS updates the specifications annually to align with current clinical guidelines and code systems so they remain relevant and actionable within the clinical care setting. CMS requires the use of the most current version of the eCQMs as specified and intended for the applicable performance periods for all quality reporting programs.

Performance period for eligible clinicians is defined as the measure data capture period of the calendar year between January 1 and December 31. The updated eCQMs are to be used by eligible clinicians to electronically report 2024 clinical quality measure data for CMS quality reporting programs. Measures will not be eligible for 2024 reporting unless and until they are proposed and finalized through notice-and-comment rulemaking for each applicable program.

Questions related to eCQM specifications, logic, data elements, standards, or resources can be submitted in the eCQM Tracker - ONC Project Tracking System (Jira).

Select Period

Filter By